<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2013-6311-854-12262</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">Att l&#xE5;ngsiktigt utrota malaria p&#xE5; &#xF6;ar: strategier f&#xF6;r eliminering av Plasmoduim vivax p&#xE5; Vanuatu</narrative>
   <narrative xml:lang="EN">Sustainable malaria freedom on islands: the strategy for Plasmodium vivax elimination in Vanuatu</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="SV">Enterotoxigenic Escherichia coli (ETEC), one of the most common causes of acute diarrhoea in developing countries, produce two main groups of virulence factors; colonization factors (CFs) and enterotoxins (ST and/or LT). The aim of this project is to study the genetic variability, infection patterns and antibiotic resistance of ETEC from several countries in Asia, Africa and Latin America as a basis for planned interventions and prophylaxis strategies, focusing on emerging toxin/CF profiles. This will be performed by Multi Locus Sequence Typing (MLST) of strains to be isolated from patients at hospitals in Bangladesh (ICDDR,B), Bolivia and Mozambique, and of strains from several other countries; sequencing of the toxin and CF genes, and correlation of the genetic findings and antibiotic resistance profiles with severity of disease, patient age, seasonality, and socioeconomic factors.</narrative>
   <narrative xml:lang="EN">For Asia Pacific sites with low and unstable malaria transmission, elimination should be feasible. The challenges have to do with Plasmodium vivax. Islands provide natural ecological experiments and a great potential for intervention studies. On Aneityum island, Vanuatu both P. falciparum and P. vivax malaria were eliminated with short-term mass drug administration (MDA) in 1991 and sustained case surveillance and vector control with a high degree of community participation. I intend to i) assess whether malaria freedom can be sustained and ii) examine the applicability of the proposed elimination strategy at the natural endemic margin to larger areas. For its evaluation annual malariometric surveys of the entire population on Aneityum will be continued in comparison with six Vanuatu islands with variable malaria transmission. I specifically aim to: 1) investigate resurgence and relate them to anti-malaria immune responses and parasite antigen diversities, 2) examine the strategy of radical MDA in concert with vector control to eliminate P. vivax infections in selected islands, 3) assess feasibility of sustainable community commitment after malaria elimination and impacts of malaria elimination on people?s gains, tourism and community development. The outcomes can serve as a model for the proposal of community-directed strategies towards sustainable malaria freedom to follow the short-term push by external donors, particularly for the areas where P. vivax can be a concern.</narrative>
  </description>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">University, college or other teaching institution, research institute or think-tank</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-01-01" type="1"></activity-date>
  <activity-date iso-date="2014-01-01" type="2"></activity-date>
  <activity-date iso-date="2016-12-31" type="3"></activity-date>
  <activity-date iso-date="2016-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="VU" percentage="100">
   <narrative xml:lang="EN">Vanuatu</narrative>
  </recipient-country>
  <sector code="122" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Basic Health</narrative>
  </sector>
  <sector code="12262" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Malaria control</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2014-01-01"></period-start>
   <period-end iso-date="2014-12-28"></period-end>
   <value currency="USD" value-date="2014-01-01">232364.9032784734</value>
  </budget>
  <budget>
   <period-start iso-date="2015-01-01"></period-start>
   <period-end iso-date="2015-12-28"></period-end>
   <value currency="USD" value-date="2015-01-01">88026.2892529629</value>
  </budget>
  <budget>
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-28"></period-end>
   <value currency="USD" value-date="2016-01-01">86717.6999941565</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2013-11-07"></transaction-date>
   <value currency="USD" value-date="2013-11-07">472578.7631271878</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-28"></transaction-date>
   <value currency="USD" value-date="2014-01-28">232364.9032784734</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-01-28"></transaction-date>
   <value currency="USD" value-date="2015-01-28">88025.8147177108</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-01-28"></transaction-date>
   <value currency="USD" value-date="2016-01-28">86717.6999941565</value>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://upload.openaid.se/document/ingen-myndighet-vald/generella-bidragsvillkor-2014.pdf">
   <title>
    <narrative xml:lang="SV">Generella bidragsvillkor 2014</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
